Sanford I. Weill Retires as Chair of the Weill Cornell Board of Overseers After 20 Years of Transformative Leadership

Body: 

Jessica M. Bibliowicz, Successful Business Executive, Named New Chair of the Board

NEW YORK (December 9, 2014) — After 20 years of bold and visionary leadership that has transformed Weill Cornell Medical College into a global healthcare enterprise, Sanford I. Weill will retire as chair of the Weill Cornell Board of Overseers on Jan. 1. Jessica M. Bibliowicz, a successful entrepreneur in the financial services business for nearly three decades, who has served on the Board of Overseers for the past decade, will succeed Mr. Weill, the new chair emeritus.

Jessica M. Bibliowicz and Sanford I. Weill

Jessica M. Bibliowicz and Sanford I. Weill. All photos: John Abbott

The transition comes as the 116-year-old medical college embarks on a new chapter that builds upon the landmark successes Mr. Weill has realized in his two decades as chair. His enduring dedication to the institution that bears his name has resulted in an unprecedented expansion that is exemplified in Weill Cornell's excellence in medical education, biomedical research and clinical care. In collaboration with medical college leadership, Ms. Bibliowicz will help lead Weill Cornell as it continues to break new ground in New York and abroad by expanding its clinical enterprise and forging public-private partnerships that accelerate groundbreaking scientific discoveries for patients. Working closely with Dr. Laurie H. Glimcher, the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College, Ms. Bibliowicz will help guide its transformation of medical education and drive dialogue on innovative healthcare delivery models that optimize the value and quality of patient care.

"When I joined the Board of Overseers more than 30 years ago, I was driven to try and make a difference in the world," Mr. Weill said. "It's truly humbling to see just how much of an impact Weill Cornell has had around the globe, and I believe we are poised to thrive far into the future. Weill Cornell Medical College is more to me than just an esteemed medical school — the people here are my extended family. I could think of no one better than Jessica to shepherd Weill Cornell into the next stage of its evolution."

"It's an honor and privilege to be able to support Weill Cornell Medical College's tremendous efforts to educate, innovate and heal," Ms. Bibliowicz said. "As a Cornell University alum, it's especially meaningful to me to try and help take this distinguished institution to the next level of excellence in New York and beyond. Our ever-changing healthcare landscape has sparked exciting opportunities to help shape national conversation, and I'm eager to work with Dr. Glimcher and the Board of Overseers as we strive to improve and prolong human health."

Dr. Laurie H. Glimcher, Sanford I. Weill and Jessica M. Bibliowicz

In the three decades he has served on the Board of Overseers and in the two decades he has been chair, Mr. Weill has been much more than a governing force. His benevolence and unwavering resolve to ensure a healthier future has touched every program area at Weill Cornell, establishing the medical school as an innovator in basic, clinical and translational research, and forging a new paradigm for global engagement and medical education.

Under Mr. Weill's leadership, the medical college has built bridges nationally and abroad. Weill Cornell forged an affiliation with Houston Methodist in Texas and, with Cornell University, established a medical school in Doha, Qatar. Since its inception in 2002, Weill Cornell Medical College in Qatar, which offers a Cornell University medical degree, has created 181 new doctors who have continued their graduate medical training in residencies and clinical research at outstanding institutions in the United States and Qatar. The Weill Cornell Qatar location has also established a world-class biomedical team and contributed to Qatar's goal of becoming a knowledge-based economy. In addition, Weill Cornell in 2007 established a formal affiliation with Bugando Medical Centre and the Weill Bugando University College of Health Sciences in Mwanza, Tanzania, named in recognition of the Weills' support. Weill Bugando has graduated an average of 100 new doctors every year for the past seven years in Mwanza, expanding Tanzania's core of providers who are empowered to deliver the best patient care, despite a resource-limited setting. This unique educational partnership has spurred new possibilities for cultural exchange, providing medical students at Weill Cornell in New York and residents at NewYork-Presbyterian Hospital with the opportunity to spend a month or two in Mwanza practicing medicine the way it used to be, with limited modern technology. They return to New York with a greater sense of gratification that reaffirms their commitment to global health and a career in academic medicine.

In recognition that building a healthier future also requires training an exceptional cadre of new doctors and scientists, Mr. Weill and his wife Joan in 1992 established the Joan and Sanford I. Weill Education Center, the heart of the medical college's education program, with their first gifts to Weill Cornell. The Weill Education Center comprises the Weill Auditorium and 20 classrooms and teaching laboratories outfitted with modern audio-visual, networking and wireless technology to provide the next generation of medical professionals with the best environment for learning.

Sanford I. Weill

In 2007, Weill Cornell opened the Weill Greenberg Center in New York City, the medical college's flagship and award-winning ambulatory care center, and in January opened the adjacent Belfer Research Building, a transformative 18-story, state-of-the-art facility that ensures that the medical college remains at the forefront of scientific discovery. Their proximity to each other ensures that breakthroughs made in the laboratory can be rapidly applied to patient care as improved treatments and therapies. Weill Cornell has successfully recruited some of the world's leading physicians and scientists to conduct this translational research. Last year, the Weills established the Weill Center for Metabolic Health, which strives to understand the basic biology and genetics of diabetes, obesity and metabolic syndrome, and translate discoveries into next-generation therapeutic approaches. Weill Cornell is conducting a national search for a renowned scientist to lead these efforts.

A self-made man who exemplifies the philosophy of leading by example, Mr. Weill, Mrs. Weill and the Weill Family Foundation have generously given more than $550 million in gifts to support Weill Cornell Medical College. They include a groundbreaking $100 million gift in 1998 — at the time the largest in Cornell University's history — a second $100 million gift in 2002, a $250 million gift in 2007 and another $100 million gift in 2013 to establish the Weill Center for Metabolic Health, as well as the Joan and Sanford I. Weill and the Weill Family Foundation Global Health Research Laboratories. In honor and appreciation of their unparalleled dedication and enduring commitment, the institution in 1998 was renamed Weill Cornell Medical College. With an additional gift of $50 million to Cornell University, the Weills' total giving tops $600 million.

The Weills' altruism inspired and galvanized Weill Cornell's numerous, loyal donors to support the medical college. In Mr. Weill's 20 years as chair, the medical college has raised $3 billion. Earlier this year, Weill Cornell celebrated the Weills' legacy by naming its department of medicine the Joan and Sanford I. Weill Department of Medicine.

"What Sandy has done for Weill Cornell, New York and the world is just breathtaking — it's a labor of love that will touch the lives of generations," Dr. Glimcher said. "His unwavering leadership, profound magnanimity and steadfast resolve to enhance medical education, advance discoveries and enrich clinical care is his lasting legacy. Jessica is an outstanding choice to assume Sandy's mantle and steer Weill Cornell into the future. I couldn't be more thrilled for what's to come."

"Sandy is a businessman, entrepreneur, philanthropist, visionary leader, chairman emeritus of Citigroup, Cornell alumnus and my good friend," said Cornell University President David Skorton. "As chair of the Board of Overseers of Weill Cornell Medical College, he has nurtured the college's growth, guided its progress and expanded its capacity for rigorous medical education, path-breaking research and superb clinical care — to the enormous benefit of our students, faculty, researchers and patients. I am delighted that Jessica Bibliowicz, who has provided exemplary leadership to the university and the medical college, has agreed to take on this new role as chair of the Board of Overseers."

"It is impossible to overstate the impact that Sandy has had on Weill Cornell Medical College, and on the whole of Cornell University, during his time as chair of the Board of Overseers," said Robert Harrison, chair of the Cornell University Board of Trustees. "He is someone who can not only articulate a strong and inspirational vision, but also bring people together to do what it takes to make the vision a reality. Although I will miss working with Sandy, I am very much looking forward to working with Jessica in her new role. She has been a very effective trustee and overseer for many years and clearly has the talent and energy to lead the Board of Overseers and the medical school to new heights."

About Jessica M. Bibliowicz

A Cornell University graduate in 1981 and after working 18 years in financial services, Ms. Bibliowicz became CEO of National Financial Partners in 1999, a financial services firm that specializes in benefits and wealth management. The company went public in 2003 and was sold to Madison Dearborn in 2013. Ms. Bibliowicz joined the Weill Cornell Board of Overseers in 2004. She is also a member of the Cornell University Board of Trustees and a member of the Cornell NYC Tech Campus Task Force. Currently, Ms. Bibliowicz is a senior advisor at Bridge Growth Partners and serves on the board of directors of Sotheby's(NYSE: BID); Realogy (NYSE: RLGY); and the Asia Pacific Fund (NYSE: APB). She is a board director/trustee of Prudential Insurance Funds and is also on the board of Jazz at Lincoln Center.

Weill Cornell Medical College

Weill Cornell Medical College, Cornell University's medical school located in New York City, is committed to excellence in research, teaching, patient care and the advancement of the art and science of medicine, locally, nationally and globally. Physicians and scientists of Weill Cornell Medical College are engaged in cutting-edge research from bench to bedside aimed at unlocking mysteries of the human body in health and sickness and toward developing new treatments and prevention strategies. In its commitment to global health and education, Weill Cornell has a strong presence in places such as Qatar, Tanzania, Haiti, Brazil, Austria and Turkey. Through the historic Weill Cornell Medical College in Qatar, Cornell University is the first in the U.S. to offer a M.D. degree overseas. Weill Cornell is the birthplace of many medical advances — including the development of the Pap test for cervical cancer, the synthesis of penicillin, the first successful embryo-biopsy pregnancy and birth in the U.S., the first clinical trial of gene therapy for Parkinson's disease, and most recently, the world's first successful use of deep brain stimulation to treat a minimally conscious brain-injured patient. Weill Cornell Medical College is affiliated with NewYork-Presbyterian Hospital, where its faculty provides comprehensive patient care at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. The Medical College is also affiliated with Houston Methodist. For more information, visit weill.cornell.edu.

Featured Image: 
Jessica M. Bibliowicz
Type of News: 
Press Releases
Mission: 
Institutional
People: 
Jessica M. Bibliowicz Sanford I. Weill Dr. Laurie H. Glimcher
Highlight this Story: 
No
Unit: 
External Affairs

Weill Cornell Medical College Names Four New Members to Board of Overseers

Body: 

New York (February 12, 2014) — Weill Cornell Medical College announced today that it has appointed physician-scientist and Nobel laureate Dr. Stanley B. Prusiner, advertising legend Edward Meyer and his wife Sandra, and physician and health policy expert Dr. Thomas Lee to its Board of Overseers. The board is responsible for governance of Weill Cornell Medical College and the Weill Cornell Graduate School of Medical Sciences.

Sandra and Edward Meyer

Dr. Prusiner is director of the Institute for Neurodegenerative Diseases and professor of neurology at the University of California, San Francisco. A world-renowned physician-scientist, Dr. Prusiner discovered an unprecedented class of pathogens — self-propagating, misshapen proteins, which he named prions — that have wide implications for many neurodegenerative diseases. Dr. Prusiner demonstrated that when prions accumulate in the brain, they cause disorders such as Creutzfeldt-Jakob disease — the human equivalent of bovine spongiform encephalopathy known colloquially as mad cow disease. Dr. Prusiner won the Lasker Award and later the Nobel Prize in Physiology or Medicine in 1997 for this seminal discovery. Much of his current research focuses on developing therapeutics that lower the levels of prions in order to prevent neurodegeneration. Dr. Prusiner is a member of the National Academy of Sciences, the Institute of Medicine, the American Academy of Arts and Sciences and the American Philosophical Society, and is a foreign member of the Royal Society in London. He is the author of more than 500 research articles and the book "Madness and Memory: The Discovery of Prions — A New Biological Principle of Disease" (Yale University Press, 2014). He has received numerous awards for his work, including the Potamkin Prize for Alzheimer's Disease Research from the American Academy of Neurology (1991), the Richard Lounsbery Award for Extraordinary Scientific Research in Biology and Medicine from the National Academy of Sciences (2003) and the United States National Medal of Science (2009). He holds 50 issued or allowed United States patents, all of which are assigned to the University of California. Dr. Prusiner received his undergraduate degree and medical school training at the University of Pennsylvania, his postgraduate clinical training at UCSF and served as a lieutenant commander in the U.S. Public Health Service at the National Institutes of Health.

Mr. Meyer is the former chairman, president and CEO of Grey Global Group, one of the world's largest advertising and marketing and communications companies. He is now chairman of Ocean Road Advisors, Inc., which directs investment and related activities. Mr. Meyer is a Cornell University alumnus, graduating with a Bachelor of Arts in economics with honors. Mrs. Meyer is a board member of the Bridgehampton Chamber Music Festival, a preeminent summer music festival on Long Island; a major supporter of Women for Women International, an institution which helps women move from crisis and poverty to stability and self-sufficiency; a member of the Group for the East End, a Long Island land conservation organization; and a member of the Women and Foreign Policy Advisory Council of the Council on Foreign Relations. Last month, the Meyer family and the Edward and Sandra Meyer Foundation gifted $75 million to Weill Cornell Medical College to expand and enhance the medical college's distinguished cancer research and care programs at the newly named Sandra and Edward Meyer Cancer Center. The Meyer Cancer Center is dedicated to using precision medicine and other cutting-edge biomedical approaches to spur and then translate research breakthroughs into the most advanced therapies for patients. In honor of the Meyer family's generous gift, Weill Cornell named its flagship building on 1300 York Ave. as the Sandra and Edward Meyer Research and Education Building.

Dr. Thomas Lee

Dr. Lee is chief medical officer for patient experience improvement firm Press Ganey Associates, Inc., bringing more than three decades of experience in health care performance improvement as a practicing physician, a leader in provider organizations, and a researcher and health policy expert. As CMO, he is responsible for developing clinical and operational strategies to advance the patient experience for health care providers across the country. Previously, he was network president for Partners Healthcare System, the integrated delivery system founded by Brigham and Women's Hospital and Massachusetts General Hospital. Dr. Lee is an internist and cardiologist, and practices primary care at Brigham and Women's Hospital in Boston. He graduated from Harvard College with a bachelor's degree in history and science, received his medical degree from Weill Cornell Medical College and earned a master's in epidemiology from the Harvard School of Public Health. Dr. Lee is a member of the boards of directors of Geisinger Health System, the Special Medical Advisory Committee of the Veterans Administration, the Panel of Health Advisors of the Congressional Budget Office, and the Editorial Board of The New England Journal of Medicine. Dr. Lee is the author of "Eugene Braunwald and the Rise of Modern Medicine" (Harvard University Press, 2013), and co-author of "Chaos and Organization in Health Care" (MIT Press, 2009).

Weill Cornell Medical College

Weill Cornell Medical College, Cornell University's medical school located in New York City, is committed to excellence in research, teaching, patient care and the advancement of the art and science of medicine, locally, nationally and globally. Physicians and scientists of Weill Cornell Medical College are engaged in cutting-edge research from bench to bedside, aimed at unlocking mysteries of the human body in health and sickness and toward developing new treatments and prevention strategies. In its commitment to global health and education, Weill Cornell has a strong presence in places such as Qatar, Tanzania, Haiti, Brazil, Austria and Turkey. Through the historic Weill Cornell Medical College in Qatar, Cornell University is the first in the U.S. to offer a M.D. degree overseas. Weill Cornell is the birthplace of many medical advances — including the development of the Pap test for cervical cancer, the synthesis of penicillin, the first successful embryo-biopsy pregnancy and birth in the U.S., the first clinical trial of gene therapy for Parkinson's disease, and most recently, the world's first successful use of deep brain stimulation to treat a minimally conscious brain-injured patient. Weill Cornell Medical College is affiliated with NewYork-Presbyterian Hospital, where its faculty provides comprehensive patient care at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. The Medical College is also affiliated with Houston Methodist. For more information, visit weill.cornell.edu.

Featured Image: 
Dr. Stanley B. Prusiner
Type of News: 
Press Releases
Highlight this Story: 
No